Opportunity Information: Apply for CDC RFA OE13 130302CONT14
Apply for CDC RFA OE13 130302CONT14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evidence Based Labortatory Medicine Labortatory Medicine Best Practices Systematic Review Recommendation Evaluation, CSELS and DLPSS" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.064 Laboratory Training, Evaluation, and Quality Assurance Programs.
- This funding opportunity was created on Mar 7, 2014 and posted on Mar 7, 2014.
- Applicants must submit their applications by Apr 8, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under CDC RFA OE13 1303, Evidence Based Labortatory Medicine Labortatory Medicine Best Practices Systematic Review Recommendation Evaluation
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, CDC RFA OE13 130302CONT14, is a continuation cooperative agreement from the Centers for Disease Control and Prevention (CDC) focused on Evidence Based Laboratory Medicine and laboratory medicine best practices, specifically supporting systematic reviews and the evaluation of recommendations. It sits within CDC programs associated with CSELS and DLPSS and is categorized under the health activity area. The listing is tied to CFDA 93.064 (Laboratory Training, Evaluation, and Quality Assurance Programs), which signals an emphasis on strengthening laboratory practice through training, evaluation methods, and quality assurance approaches that can be applied across public health and clinical laboratory settings.
The purpose, as indicated by the title and description, is to sustain work that identifies what laboratory practices work best, assesses the strength and quality of the underlying evidence, and translates that evidence into usable recommendations. In practical terms, this kind of program typically supports structured evidence review processes (systematic reviews) that compile and assess research on laboratory testing and laboratory practice questions, and then evaluate or refine recommendations so they are defensible, transparent, and implementable. The overall theme is not basic research, but rather evidence synthesis and best-practice evaluation that can improve the reliability, effectiveness, and quality of laboratory medicine.
The award mechanism is a cooperative agreement, which generally means the CDC expects to have substantial programmatic involvement compared with a standard grant. While the notice itself does not provide operational details, cooperative agreements in this space often involve close collaboration with CDC subject matter experts on topics such as review questions, methods for evidence grading, stakeholder input, and dissemination of findings into guidance or best-practice materials. The opportunity category is listed as continuation, reinforcing that it is meant to keep existing projects running rather than start new, unrelated ones.
Eligibility is tightly limited. The announcement states that this is a continuation of funds intended only for grantees previously awarded under CDC RFA OE13 1303, which has the same Evidence Based Laboratory Medicine best practices systematic review and recommendation evaluation focus. As a result, new applicants who were not part of the original award cohort would not be eligible for this continuation funding, even though the general eligibility line is presented as "Others (see text field entitled Additional Information on Eligibility for clarification)." The clarification provided effectively restricts eligibility to prior awardees under the earlier funding opportunity.
From an administrative standpoint, the posting and creation date were March 7, 2014, with an original and current closing date of April 8, 2014, and the archive date of May 8, 2014, indicating the opportunity is historical and no longer open. The CDC listed an expectation of four awards. No cost sharing or matching requirement is indicated, meaning awardees were not required to contribute non-federal funds as a condition of the award. The estimated total funding is shown as 0 in the source data, which often reflects that the total amount was not entered into that field in the public notice rather than implying no funds would be distributed, especially since it is explicitly framed as a continuation of funds.
For applicants who were eligible at the time (the original grantees), this continuation would have represented ongoing support to maintain momentum in evidence-based laboratory medicine activities, including continuing systematic review workflows, updating or validating recommendation frameworks, and supporting dissemination or implementation considerations for best practices. The CDC provided contact support through CDC/PGO for anyone who had trouble accessing the full announcement electronically, with a phone number (770-488-2700) and email (pgotim@cdc.gov), which is typical for federal opportunity postings where official guidance and application instructions may be contained in the full announcement package.
Frequently Asked Questions (FAQs)
What is the funding opportunity called?
The opportunity is titled CDC RFA OE13 130302CONT14. It is described as a continuation cooperative agreement from the Centers for Disease Control and Prevention (CDC) focused on Evidence Based Laboratory Medicine and laboratory medicine best practices.
What is the main purpose of this continuation funding?
The stated purpose is to sustain work that identifies which laboratory practices work best, evaluates the strength and quality of the underlying evidence, and translates that evidence into usable recommendations. The emphasis is on systematic reviews and evaluation of recommendations, not on basic or exploratory research.
What kinds of activities does this opportunity support?
Based on the description provided, the supported work centers on structured evidence review processes (systematic reviews) that compile and assess research on laboratory testing and laboratory practice questions, and then evaluate, refine, or support recommendations so they are defensible, transparent, and implementable. The work aligns with evidence synthesis and best-practice evaluation intended to improve reliability, effectiveness, and quality in laboratory medicine.
Is this opportunity focused on basic research?
No. The overall theme is evidence synthesis (such as systematic reviews) and best-practice evaluation and recommendation assessment. It is presented as work that strengthens and improves laboratory practice rather than conducting basic research.
What is the award mechanism?
The award mechanism is a cooperative agreement. This generally indicates substantial CDC programmatic involvement compared with a standard grant, often involving close collaboration with CDC subject matter experts on review topics, evidence grading methods, stakeholder input, and dissemination of findings.
What does it mean that this is a "continuation" opportunity?
"Continuation" indicates the funding is meant to keep existing projects running rather than start new, unrelated ones. In this case, it is specifically framed as a continuation of funds for prior projects tied to an earlier CDC funding opportunity.
Who is eligible to apply?
Eligibility is tightly restricted. The continuation is intended only for grantees previously awarded under CDC RFA OE13 1303, which is described as having the same Evidence Based Laboratory Medicine systematic review and recommendation evaluation focus. New applicants who were not part of the original award cohort would not be eligible for this continuation funding.
The eligibility line says "Others" - does that mean anyone can apply?
No. Although the general eligibility line is presented as "Others (see text field entitled Additional Information on Eligibility for clarification)," the clarification effectively restricts eligibility to prior awardees under CDC RFA OE13 1303.
Which CDC programs is this opportunity associated with?
The opportunity sits within CDC programs associated with CSELS and DLPSS, as described in the provided information.
What is the activity area or category for this opportunity?
It is categorized under the health activity area.
What CFDA number is tied to this listing, and what does it signal?
The listing is tied to CFDA 93.064 (Laboratory Training, Evaluation, and Quality Assurance Programs). This signals an emphasis on strengthening laboratory practice through training, evaluation methods, and quality assurance approaches that can be applied across public health and clinical laboratory settings.
How many awards were expected?
The CDC listed an expectation of four awards.
Is cost sharing or matching required?
No cost sharing or matching requirement is indicated in the provided information. That means awardees were not required to contribute non-federal funds as a condition of the award, based on what is stated.
Why does the estimated total funding show as 0?
The estimated total funding is shown as 0 in the source data. As described, this often reflects that the total amount was not entered into that field in the public notice rather than indicating that no funds would be distributed, especially since the opportunity is explicitly framed as a continuation of funds.
When was this opportunity posted and when did it close?
The posting and creation date were March 7, 2014. The original and current closing date were April 8, 2014. The archive date was May 8, 2014.
Is this funding opportunity still open?
No. The dates provided indicate the opportunity is historical and no longer open (it closed April 8, 2014 and was archived May 8, 2014).
What types of outcomes are implied by the opportunity description?
The description implies outcomes such as continued systematic review workflows, updated or validated recommendation frameworks, and support for dissemination or implementation considerations for laboratory medicine best practices, consistent with sustaining evidence-based laboratory medicine activities.
How would applicants access the full announcement or get help if they had trouble accessing it?
The CDC provided contact support through CDC/PGO for those who had trouble accessing the full announcement electronically. The contact details provided are phone 770-488-2700 and email pgotim@cdc.gov.
Who is the listed point of contact?
The provided information lists CDC/PGO as the contact support point, with phone 770-488-2700 and email pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: FY 2014 and FY 2015 National Wetland Program Development Grants
Previous opportunity: PROJECT SOAR
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA OE13 130302CONT14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA OE13 130302CONT14) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cooperative Agreements to Benefit Homeless Individuals States Supplement (Short Title CABHI States Supplement) Apply for SM 14 012 Funding Number: SM 14 012 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $499,351 |
| Collaboration for Improving Promoting Standardized Cancer Staging Using the Collaborative Stage Data Collection System Apply for CDC RFA DP13 131002CONT14 Funding Number: CDC RFA DP13 131002CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Evaluation of AHRQ Initiative to Accelerate the Dissemination and Implementation of PCOR Findings into Primary Care (R01) Apply for RFA HS 14 009 Funding Number: RFA HS 14 009 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Accelerating the Dissemination and Implementation of PCOR Findings into Primary Care Practice (R18) Apply for RFA HS 14 008 Funding Number: RFA HS 14 008 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Act Against AIDS Leadership Initiative Apply for CDC RFA PS10 105705CONT14 Funding Number: CDC RFA PS10 105705CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Comprehensive Asthma Control Through Evidence based Strategies and Public HealthHealth Care Collaboration Apply for CDC RFA EH14 1404 Funding Number: CDC RFA EH14 1404 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01) Apply for RFA AI 14 019 Funding Number: RFA AI 14 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| To Strengthen Collaboration between CDC and the National TB Controller and the National TB Nurse Coalition Apply for CDC RFA PS12 120503CONT14 Funding Number: CDC RFA PS12 120503CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY14 Announcement of Availability of Funds for Embryo Donation and/or Adoption Grant Projects Apply for PA EAA 14 002 Funding Number: PA EAA 14 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| Public Health Systems Capacity Building in Central Asia Apply for CDC RFA GH14 1417 Funding Number: CDC RFA GH14 1417 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| R40 MCH Autism Intervention Research Program Apply for HRSA 14 037 Funding Number: HRSA 14 037 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 MCH Autism Secondary Data Analysis Studies (SDAS) Program Apply for HRSA 14 125 Funding Number: HRSA 14 125 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| R40 MCH Autism Longitudinal Data Project Apply for HRSA 14 127 Funding Number: HRSA 14 127 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Temporal Dynamics of Neurophysiological Patterns as Potential Targets for Treating Cognitive Deficits in Brain Disorders (R01) Apply for PAR 14 153 Funding Number: PAR 14 153 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Temporal Dynamics of Neurophysiological Patterns as Potential Targets for Treating Cognitive Deficits in Brain Disorders (R21) Apply for PAR 14 158 Funding Number: PAR 14 158 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Strategic Prevention Framework Partnerships for Success State and Tribal Initiative (SPF PFS) Apply for SP 14 004 Funding Number: SP 14 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,016,000 |
| Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis TIPS) among Non urban Young Persons Who Inject Drugs Apply for RFA PS 14 OO4 Funding Number: RFA PS 14 OO4 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Secretarys Minority AIDS Initiative Funding for Apply for CDC RFA PS12 121003CONT14 Funding Number: CDC RFA PS12 121003CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Planning and Management of a Public Health Communication and Community Engagement Technical Assistance Cooperative Agreement Apply for CDC RFA CD11 110104CONT14 Funding Number: CDC RFA CD11 110104CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Development, Operation, and Evaulation of an Entertainment Education Program Apply for CDC RFA CD12 120103CONT14 Funding Number: CDC RFA CD12 120103CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA OE13 130302CONT14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.